AKUMS DRUGS & PHARMACEUTICALS
|
AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Balance Sheet History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹29 Cr | ₹29 Cr | ₹14 Cr | ₹1.30 Cr | ₹1.30 Cr |
Equity - Authorised | ₹40 Cr | ₹30 Cr | ₹15 Cr | ₹1.50 Cr | ₹1.50 Cr |
Equity - Issued | ₹29 Cr | ₹29 Cr | ₹14 Cr | ₹1.30 Cr | ₹1.30 Cr |
Equity Paid Up | ₹29 Cr | ₹29 Cr | ₹14 Cr | ₹1.30 Cr | ₹1.30 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹2.00 | ₹2.00 | ₹2.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | - | - | - | - | - |
Total Reserves | ₹681 Cr | ₹689 Cr | ₹608 Cr | ₹884 Cr | ₹721 Cr |
Securities Premium | ₹127 Cr | ₹127 Cr | ₹127 Cr | ₹128 Cr | ₹128 Cr |
Capital Reserves | ₹103 Cr | ₹103 Cr | ₹103 Cr | ₹103 Cr | ₹2.20 Cr |
Profit & Loss Account Balance | ₹631 Cr | ₹639 Cr | ₹558 Cr | ₹832 Cr | ₹771 Cr |
General Reserves | - | - | - | - | - |
Other Reserves | ₹-180 Cr | ₹-180 Cr | ₹-180 Cr | ₹-180 Cr | ₹-180 Cr |
Reserve excluding Revaluation Reserve | ₹681 Cr | ₹689 Cr | ₹608 Cr | ₹884 Cr | ₹721 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹709 Cr | ₹717 Cr | ₹622 Cr | ₹885 Cr | ₹722 Cr |
Minority Interest | ₹11 Cr | ₹6.19 Cr | ₹3.20 Cr | ₹2.29 Cr | ₹-1.52 Cr |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹78 Cr | ₹115 Cr | ₹13 Cr | - | ₹9.85 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹124 Cr | ₹149 Cr | ₹20 Cr | ₹9.85 Cr | ₹45 Cr |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹-46 Cr | ₹-34 Cr | ₹-6.69 Cr | ₹-9.85 Cr | ₹-35 Cr |
Unsecured Loans | - | - | - | ₹1.16 Cr | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | ₹1.16 Cr | - |
Other Unsecured Loan | - | - | - | - | - |
Deferred Tax Assets / Liabilities | ₹-111 Cr | ₹-6.22 Cr | ₹20 Cr | ₹27 Cr | ₹33 Cr |
Deferred Tax Assets | ₹194 Cr | ₹82 Cr | ₹43 Cr | ₹40 Cr | ₹41 Cr |
Deferred Tax Liability | ₹83 Cr | ₹76 Cr | ₹64 Cr | ₹66 Cr | ₹75 Cr |
Other Long Term Liabilities | ₹1,464 Cr | ₹1,111 Cr | ₹1,095 Cr | ₹637 Cr | ₹524 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹31 Cr | ₹26 Cr | ₹24 Cr | ₹20 Cr | ₹19 Cr |
Total Non-Current Liabilities | ₹1,462 Cr | ₹1,246 Cr | ₹1,153 Cr | ₹685 Cr | ₹586 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹532 Cr | ₹567 Cr | ₹590 Cr | ₹341 Cr | ₹423 Cr |
Sundry Creditors | ₹532 Cr | ₹567 Cr | ₹590 Cr | ₹341 Cr | ₹423 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹253 Cr | ₹246 Cr | ₹238 Cr | ₹84 Cr | ₹110 Cr |
Bank Overdraft / Short term credit | - | ₹3.77 Cr | ₹4.81 Cr | ₹1.66 Cr | - |
Advances received from customers | ₹112 Cr | ₹108 Cr | ₹145 Cr | ₹17 Cr | ₹21 Cr |
Interest Accrued But Not Due | - | - | - | ₹0.42 Cr | ₹0.42 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹141 Cr | ₹134 Cr | ₹88 Cr | ₹65 Cr | ₹89 Cr |
Short Term Borrowings | ₹368 Cr | ₹388 Cr | ₹338 Cr | ₹86 Cr | ₹130 Cr |
Secured ST Loans repayable on Demands | ₹267 Cr | ₹388 Cr | ₹338 Cr | ₹86 Cr | ₹130 Cr |
Working Capital Loans- Sec | ₹267 Cr | ₹388 Cr | ₹338 Cr | ₹86 Cr | ₹130 Cr |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-167 Cr | ₹-388 Cr | ₹-338 Cr | ₹-86 Cr | ₹-130 Cr |
Short Term Provisions | ₹58 Cr | ₹65 Cr | ₹107 Cr | ₹68 Cr | ₹67 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹1.44 Cr | ₹19 Cr | ₹48 Cr | ₹29 Cr | ₹22 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹57 Cr | ₹46 Cr | ₹59 Cr | ₹39 Cr | ₹45 Cr |
Total Current Liabilities | ₹1,211 Cr | ₹1,266 Cr | ₹1,272 Cr | ₹580 Cr | ₹730 Cr |
Total Liabilities | ₹3,393 Cr | ₹3,235 Cr | ₹3,050 Cr | ₹2,152 Cr | ₹2,037 Cr |
ASSETS | |||||
Gross Block | ₹1,929 Cr | ₹1,715 Cr | ₹1,542 Cr | ₹1,325 Cr | ₹992 Cr |
Less: Accumulated Depreciation | ₹739 Cr | ₹617 Cr | ₹521 Cr | ₹421 Cr | ₹348 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹1,191 Cr | ₹1,097 Cr | ₹1,021 Cr | ₹904 Cr | ₹644 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹195 Cr | ₹103 Cr | ₹31 Cr | ₹17 Cr | ₹57 Cr |
Non Current Investments | ₹0.14 Cr | ₹0.14 Cr | ₹0.39 Cr | ₹0.53 Cr | ₹0.56 Cr |
Long Term Investment | ₹0.14 Cr | ₹0.14 Cr | ₹0.39 Cr | ₹0.53 Cr | ₹0.56 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹0.14 Cr | ₹0.14 Cr | ₹0.39 Cr | ₹0.53 Cr | ₹0.56 Cr |
Long Term Loans & Advances | ₹56 Cr | ₹96 Cr | ₹86 Cr | ₹44 Cr | ₹36 Cr |
Other Non Current Assets | ₹9.74 Cr | ₹14 Cr | ₹20 Cr | ₹29 Cr | ₹50 Cr |
Total Non-Current Assets | ₹1,452 Cr | ₹1,311 Cr | ₹1,159 Cr | ₹995 Cr | ₹787 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | - | - | - | ₹19 Cr | ₹5.84 Cr |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | ₹19 Cr | ₹5.84 Cr |
Inventories | ₹630 Cr | ₹730 Cr | ₹722 Cr | ₹430 Cr | ₹398 Cr |
Raw Materials | ₹304 Cr | ₹362 Cr | ₹335 Cr | ₹177 Cr | ₹181 Cr |
Work-in Progress | ₹71 Cr | ₹77 Cr | ₹67 Cr | ₹34 Cr | ₹49 Cr |
Finished Goods | ₹109 Cr | ₹130 Cr | ₹160 Cr | ₹97 Cr | ₹38 Cr |
Packing Materials | ₹65 Cr | ₹82 Cr | ₹81 Cr | ₹50 Cr | ₹50 Cr |
Stores and Spare | ₹13 Cr | ₹12 Cr | ₹12 Cr | ₹6.56 Cr | ₹2.28 Cr |
Other Inventory | ₹68 Cr | ₹67 Cr | ₹67 Cr | ₹65 Cr | ₹77 Cr |
Sundry Debtors | ₹834 Cr | ₹845 Cr | ₹884 Cr | ₹531 Cr | ₹582 Cr |
Debtors more than Six months | ₹107 Cr | ₹151 Cr | ₹83 Cr | ₹545 Cr | ₹5.78 Cr |
Debtors Others | ₹750 Cr | ₹709 Cr | ₹819 Cr | - | ₹582 Cr |
Cash and Bank | ₹277 Cr | ₹150 Cr | ₹103 Cr | ₹68 Cr | ₹147 Cr |
Cash in hand | ₹0.33 Cr | ₹0.25 Cr | ₹0.41 Cr | ₹0.53 Cr | ₹0.52 Cr |
Balances at Bank | ₹277 Cr | ₹150 Cr | ₹102 Cr | ₹67 Cr | ₹147 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹30 Cr | ₹15 Cr | ₹9.49 Cr | ₹10 Cr | ₹13 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | ₹0.54 Cr |
Prepaid Expenses | ₹13 Cr | ₹9.10 Cr | ₹7.94 Cr | ₹6.47 Cr | ₹4.76 Cr |
Other current_assets | ₹17 Cr | ₹5.61 Cr | ₹1.55 Cr | ₹3.82 Cr | ₹7.35 Cr |
Short Term Loans and Advances | ₹169 Cr | ₹139 Cr | ₹145 Cr | ₹99 Cr | ₹104 Cr |
Advances recoverable in cash or in kind | ₹20 Cr | ₹25 Cr | ₹20 Cr | ₹17 Cr | ₹12 Cr |
Advance income tax and TDS | - | ₹11 Cr | - | ₹0.16 Cr | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹149 Cr | ₹103 Cr | ₹125 Cr | ₹82 Cr | ₹92 Cr |
Total Current Assets | ₹1,941 Cr | ₹1,879 Cr | ₹1,864 Cr | ₹1,157 Cr | ₹1,250 Cr |
Net Current Assets (Including Current Investments) | ₹730 Cr | ₹613 Cr | ₹592 Cr | ₹577 Cr | ₹520 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹3,393 Cr | ₹3,235 Cr | ₹3,050 Cr | ₹2,152 Cr | ₹2,037 Cr |
Contingent Liabilities | ₹89 Cr | ₹82 Cr | ₹98 Cr | ₹22 Cr | ₹19 Cr |
Total Debt | ₹492 Cr | ₹537 Cr | ₹358 Cr | ₹97 Cr | ₹175 Cr |
Book Value | 49.59 | 50.13 | 86.95 | 6,801.28 | 5,554.34 |
Adjusted Book Value | 49.59 | 50.13 | 43.47 | 61.83 | 50.49 |
Compare Balance Sheet of peers of AKUMS DRUGS & PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AKUMS DRUGS & PHARMACEUTICALS | ₹7,474.9 Cr | 4% | 4.4% | NA | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹411,306.0 Cr | -2.5% | 7.6% | 4.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹150,343.0 Cr | -3% | 3.4% | 61.5% | Stock Analytics | |
CIPLA | ₹117,323.0 Cr | -1.6% | 3% | -3.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹108,619.0 Cr | -0.3% | 9% | 22.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹95,941.5 Cr | -1.2% | 2.9% | -6.4% | Stock Analytics |
AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AKUMS DRUGS & PHARMACEUTICALS | 4% |
4.4% |
|
SENSEX | -1.8% |
2.7% |
5% |
You may also like the below Video Courses